Gribbles Pathology began in South Australia when Dr. Eugene McLachlan established a small laboratory adjunct to his practice in 1936. It continued to grow and in 1989, Gribbles expanded its medical services to the state of Victoria. The organization grew rapidly, with Gribbles Pathology Australia now comprising over 45 state-of-the-art NATA accredited laboratories and 227 approved collection centres located in Victoria, South Australia, Western Australia, New South Wales, Queensland, Tasmania and the Northern Territory. Today, it is an international pathology group headquartered in Australia with major operations in New Zealand, Malaysia, Singapore and Brunei.

Gribbles Pathology is part of the Gribbles Group, an organization that has a vision of delivering a diverse range of quality diagnostic services. The Gribbles Group is made up of 3 business units that are Gribbles Pathology, Molecular Science and Gribbles Veterinary Pathology.

The Gribbles Group is now one of the 3 largest pathology providers in Australia with over 45 laboratories throughout Australia. The laboratories are equipped with state-of-the-art automated instruments directly interfaced with a LIS (Laboratory Information System). In Australia, Gribbles perform tests for over 3 million patients per year.

The Gribbles Group employs over 3,000 staff in Australia, New Zealand and internationally, in various divisions and departments, the majority with scientific, technical, nursing and other higher qualifications. All laboratories work closely together with frequent interchange of senior staff and testing. This has the major benefit of enabling expertise and training to be shared throughout the organization.

The Gribbles Group was acquired by Healthscope Limited in December 2004, bringing synergy between the hospital business of Healthscope and the pathology business of the Gribbles Group. Today Healthscope Limited operates 47 hospitals and is Australia’s second largest private health care operator. It boasts annual revenues of over AUD$1.1 Billion and has a market capitalization of over AUD$1 Billion.

Together, Healthscope and the Gribbles Group provide high quality hospital and diagnostic services operating to the highest international standards.

For more information on Gribbles Australia and Healthscope, kindly click here.

DIRECTOR OF PATHOLOGY
Dr A J Matthew Egan                                                                        MBBS, BMedSc, FRCPA, MBA
Dr Egan graduated with honours from the University of Queensland and went on to train in Histopathology at Sydney’s Royal Prince Alfred Hospital. He then held the position of Fellow at the Mayo Clinic in Minnesota, USA for one year where he developed an interest in urological and pulmonary pathology. Dr Egan completed his MBA at Melbourne Business School and joined The Gribbles Group in February 2005. He was appointed as Director of Pathology in December 2005.